ABBV: A Safe 4.7% Yield in Biopharma By: TalkMarkets January 20, 2021 at 19:19 PM EST Even with the slightly lower free cash flow total in 2019, AbbVie had more than enough to afford the $6.4 billion in dividends that it paid. Read More >> Related Stocks: AbbVie Abbott Laboratories